Skip to main content
Equibles

BANK OF AMERICA CORP /DE/

Bank

Position in ZTS — Zoetis Inc.

CIK 70858 CHARLOTTE, NC
Back to ZTS Full portfolio

Position in ZTS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$282,045,178
-$289,104,401 QoQ
Shares Held
3,924,926
-18.8% QoQ
Ownership
0.950%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#20
of 1,408 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 70% Shared 0% None 30%

Common Shares in ZTS Over Time

Shares Held

Position Value (USD)

Derivatives in ZTS

reported options exposure · as of Sep 30, 2025
CallValue
$190,216
CallShares
1,300
PutValue
$204,848
PutShares
1,400

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

BANK OF AMERICA CORP /DE/ holds $1,596,028,663 across 49 Drug Manufacturers - Specialty & Generic names. ZTS ranks #1 (17.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZTS
Zoetis Inc.
This page 		3,924,926 $282,045,178
2 LQDA
Liquidia Corp
 1,991,566 $158,787,554
3 TEVA
Teva Pharmaceutical Industries Ltd
 4,227,607 $143,231,322
4 VTRS
Viatris Inc
 7,356,708 $116,824,520
5 NBIX
Neurocrine Biosciences Inc
 619,352 $104,385,582
6 HLN
Haleon plc
 10,850,097 $101,231,403
7 UTHR
UNITED THERAPEUTICS Corp
 179,235 $97,114,896
8 ELAN
Elanco Animal Health Inc
 3,909,871 $96,221,922

All Filings in ZTS

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $282,045,178 3,924,926
2026-03-31 $571,149,579 4,831,652
2025-12-31 $566,735,928 4,504,339
2025-09-30 $190,216 1,300
2025-09-30 $204,848 1,400
2025-09-30 $875,001,497 5,980,054
2025-06-30 $4,117,080 26,400
2025-06-30 $202,735 1,300
2025-06-30 $1,100,151,454 7,054,514
2025-03-31 $214,045 1,300
2025-03-31 $148,185 900
2025-03-31 $1,206,809,417 7,329,544
2024-12-31 $1,873,189,098 11,496,895
2024-09-30 $2,805,456,140 14,358,973
2024-09-30 $3,946,676 20,200
2024-09-30 $1,074,590 5,500
2024-06-30 $2,219,008 12,800
2024-06-30 $2,616,267,117 15,091,527
2024-03-31 $28,105,781 166,100
2024-03-31 $1,692,100 10,000
2024-03-31 $2,362,717,467 13,963,226
2023-12-31 $3,947,400 20,000
2023-12-31 $2,665,669,939 13,505,953
2023-09-30 $16,354,120 94,000
2023-09-30 $2,131,390,875 12,250,781
2023-06-30 $1,968,268,506 11,429,467
2023-03-31 $2,365,619,873 14,213,049
2023-03-31 $25,348,812 152,300
2022-12-31 $2,073,183,639 14,146,596
2022-12-31 $1,465,500 10,000
2022-09-30 $1,724,538,847 11,629,502
2022-06-30 $2,045,919,173 11,902,491
2022-03-31 $2,409,396,981 12,775,847
2021-12-31 $3,587,241 14,700
2021-12-31 $7,003,661 28,700
2021-12-31 $3,102,050,544 12,711,759
2021-09-30 $2,503,165,441 12,893,610
2021-09-30 $2,853,858 14,700
2021-09-30 $5,571,818 28,700
2021-06-30 $5,348,532 28,700
2021-06-30 $2,739,492 14,700
2021-06-30 $2,357,660,856 12,651,110
2021-03-31 $2,034,312,937 12,917,913
2021-03-31 $4,409,440 28,000
2021-03-31 $2,299,208 14,600
2020-12-31 $2,220,173,892 13,414,948
2020-09-30 $2,233,576,517 13,506,540
2020-06-30 $685,200 5,000
2020-06-30 $465,936 3,400
2020-06-30 $1,773,805,330 12,943,705

Report a Problem

Category
Description
Email (optional, for follow-up)